Valicare extends GxP expertise for pharma, biotech and ATMP

New consulting services for the transition from development to clinical manufacturing

0
83
GxP
Valicare is a renowned expert for GxP compliance support, focusing on aseptic filling processes and ATMP manufacturing. Photo - Valicare

Valicare, a wholly-owned subsidiary of Syntegon, now offers additional services along the entire product life cycle of pharmaceutically and biotechnologically produced drugs. A new focus is on consulting services to transition products from the development phase to the GMP compliant manufacturing of investigational medicinal products. These services are complemented by the presentation and assessment of market-specific requirements, investigational drug management, and the necessary regulatory interactions.

Valicare has been a GMP consulting service provider with headquarter in Frankfurt, Germany, since 2002. More than 100 natural scientists and engineers support the pharma, biotech, and medical technology industry with a broad GxP services portfolio. Valicare is a subsidiary of Syntegon, a global supplier of process and packaging technology for the pharmaceutical and food industries. Valicare is a renowned expert for GxP compliance support, focusing on aseptic filling processes and ATMP manufacturing.

Addition to the team

Dr Christin Erbach

To underline the extension of the service portfolio, Valicare has recruited Dr Christin Erbach to join the expert team of engineers and scientists as a senior GMP consultant. Dr Erbach has more than ten years of clinical service experience and in-depth knowledge of quality management and legal pharmaceutical requirements. She also successfully supported pharmaceutical businesses during their establishment phase.

“Her specialized knowledge in the area of clinical services combined with her legal background is an outstanding addition to Valicare’s consultancy business,” says Dr Hans-Georg Eckert, site manager of Valicare in Frankfurt. “She will strengthen our competencies regarding the first GMP steps and the legal requirements for clinical products, addressing special needs for each development stage. This way, we are able to extend our approach of accompanying products along their complete life cycle.”

Valicare is significantly expanding its GxP and consultancy services for the pharma, biotech, and advanced therapy medicinal product (ATMP) industries to fulfill individual demands regarding products and projects from development to market release. As far as ATMPs are concerned, the company already supports customers in meeting regulatory requirements for more individual therapies and minimizing associated risks. Valicare also offers complete solutions to produce ATMPs and consulting and supporting services, right through to the production of the first investigational medicinal products.

 

As you join us today from India and elsewhere, we have a favour to ask. Through these times of ambiguity and challenge, the packaging industry in India and in most parts of the world has been fortunate. We are now read in more than 90 countries as our coverage widens and increases in impact. Our traffic as per analytics more than doubled in 2020 and many readers chose to support us financially even when advertising fell to pieces.

As we come out of the pandemic in the next few months, we hope to again expand our geography and evolve our high-impact reporting and authoritative and technical information, with some of the best correspondents in the industry. If there were ever a time to support us, it is now. You can power Packaging South Asia’s balanced industry journalism and help to sustain us by subscribing.

Subscribe Now

LEAVE A REPLY

Please enter your comment!
Please enter your name here